1. Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination
- Author
-
Can Huang, Makoto Miyagishi, Wenfang Li, Hezhao Zhao, Vivi Kasim, Arin Herkilini, and Shourong Wu
- Subjects
Cyclin-Dependent Kinase Inhibitor p21 ,Male ,0301 basic medicine ,Therapeutic gene modulation ,Gene isoform ,Research paper ,p53 ubiquitination ,p52-ZER6 ,Models, Biological ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,0302 clinical medicine ,Cell Line, Tumor ,parasitic diseases ,Humans ,Protein Interaction Domains and Motifs ,Zinc finger ,Gene knockdown ,ZER6 ,biology ,Oncogene ,Chemistry ,Cell growth ,Cell Cycle ,Ubiquitination ,Proto-Oncogene Proteins c-mdm2 ,Zinc Fingers ,General Medicine ,Cell cycle ,Immunohistochemistry ,Cell biology ,Cell Transformation, Neoplastic ,030104 developmental biology ,030220 oncology & carcinogenesis ,biology.protein ,Mdm2 ,Zinc-finger protein ,Tumor Suppressor Protein p53 ,Colorectal Neoplasms ,Biomarkers ,Protein Binding ,Signal Transduction - Abstract
Background Aberrant expression of p53 and its downstream gene p21 is closely related to alterations in cell cycle and cell proliferation, and is common among cancer patients. However, the underlying molecular mechanism has not been fully unravelled. ZER6 is a zinc-finger protein with two isoforms possessing different amino termini (N-termini) in their proteins, p52-ZER6 and p71-ZER6. The biological function of ZER6 isoforms, as well as their potential involvement in tumourigenesis and the regulation of p53 remain elusive. Methods The effect of ZER6 isoforms on p53 and p21 was determined using specific knockdown and overexpression. p52-ZER6 expression in tumours was analysed using clinical specimens, while gene modulation was used to explore p52-ZER6 roles in regulating cell proliferation and tumourigenesis. The mechanism of p52-ZER6 regulation on the p53/p21 axis was studied using molecular biology and biochemical methods. Findings p52-ZER6 was highly expressed in tumour tissues, and was closely related with tumour progression. Mechanistically, p52-ZER6 bound to p53 through a truncated KRAB (tKRAB) domain in its N-terminus and enhanced MDM2/p53 complex integrity, leading to increased p53 ubiquitination and degradation. p52-ZER6-silencing induced G0-G1 phase arrest, and subsequently reduced cell proliferation and tumourigenesis. Intriguingly, this regulation on p53 was specific to p52-ZER6, whereas p71-ZER6 did not affect p53 stability, most likely due to the presence of a HUB-1 domain. Interpretation We identified p52-ZER6 as a novel oncogene that enhances MDM2/p53 complex integrity, and might be a potential target for anti-cancer therapy.
- Published
- 2019
- Full Text
- View/download PDF